Spheroids reveal hypoxia‑driven spatial restriction of adenoviral infection

Tamara Büttner1, Xiaoyan Wang2, Brenda Krishnacoumar1

  • 1Institute of Physiology, University of Duisburg-Essen, University Hospital Essen, Essen, Germany.

Scientific Reports
|May 21, 2026
PubMed

Insights

Hypoxia, low oxygen, hinders oncolytic adenovirus therapy by reducing viral protein production and limiting infection spread in 3D tumor models. This highlights the need for hypoxia-aware preclinical studies.

Area of Science:

  • Oncology
  • Virology
  • Biomedical Engineering

Background:

  • Hypoxia is common in solid tumors and impedes cancer therapies.
  • Adenoviruses are promising oncolytic agents, but hypoxia's effect on their efficacy is unclear.

Purpose of the Study:

  • To investigate how oxygen levels affect adenovirus infection and spread.
  • To evaluate adenovirus efficacy in 2D cultures and 3D tumor spheroids under varying oxygen conditions.

Main Methods:

  • Utilized HEK293A, A549, and KP4 cancer cell lines.
  • Assessed adenoviral protein production under normoxia and hypoxia.
  • Analyzed spatial infection patterns of HAdV5_GFP in 3D KP4 tumor spheroids.

Main Results:

  • Hypoxia significantly reduced adenoviral protein production in KP4 cells.
  • In 3D spheroids, hypoxia restricted HAdV5_GFP infection to the outer rim when virus was added during hypoxia development.
  • Normoxic inoculation in 3D spheroids led to more uniform infection distribution.

Conclusions:

  • Tumor-associated hypoxia suppresses adenovirus replication and alters infection spatial distribution.
  • 3D tumor models are crucial for preclinical evaluation of oncolytic adenoviruses in hypoxia-relevant conditions.

Related Concept Videos